Form 4 · Filed May 29, 2026, 08:04 PM UTC
IMVT/Immunovant, Inc.
Fromkin Andrew J. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
10 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 28, 2026 | M | other | 31,668 | $5 | $158,023 | 131,400 |
| May 28, 2026 | M | other | 71,492 | $8 | $567,646 | 202,892 |
| May 28, 2026 | M | other | 77,181 | $8 | $650,636 | 280,073 |
| May 28, 2026 | M | other | 16,260 | $15 | $239,022 | 296,333 |
| May 28, 2026 | S | sell | 11,483 | $33 | $374,805 | 284,850 |
| May 28, 2026 | S | sell | 210,468 | $34 | $7,063,306 | 74,382 |
| May 28, 2026 | M | other | 31,668 | — | — | 0 |
| May 28, 2026 | M | other | 71,492 | — | — | 0 |
| May 28, 2026 | M | other | 77,181 | — | — | 0 |
| May 28, 2026 | M | other | 16,260 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001341896-26-000004